Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Dec 30, 2024 | (FY)Dec 30, 2023 | (FY)Dec 30, 2022 | (FY)Dec 30, 2021 | (FY)Dec 30, 2020 | (FY)Dec 30, 2019 | (FY)Dec 30, 2018 | (FY)Dec 30, 2017 | (FY)Dec 30, 2016 | (FY)Dec 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | 3.28%2.99B | 0.31%2.9B | 17.97%2.89B | 14.63%2.45B | -27.13%2.14B | -0.32%2.93B | 1.58%2.94B | 0.44%2.9B | -6.65%2.88B | 5.70%3.09B |
| Revenue from customers | 3.28%2.99B | 1.51%2.9B | 16.57%2.85B | 14.63%2.45B | -27.13%2.14B | -0.32%2.93B | 5.30%2.94B | -3.12%2.79B | -6.65%2.88B | 5.91%3.09B |
| Other cash income from operating activities | ---- | ---- | --34.3M | ---- | ---- | ---- | ---- | --102.4M | ---- | ---- |
| Cash paid | -8.37%-994.6M | 2.21%-917.8M | -21.10%-938.5M | -13.25%-775M | 28.88%-684.3M | -3.36%-962.2M | -3.33%-930.9M | 11.15%-900.9M | 9.57%-1.01B | 2.48%-1.12B |
| Payments to suppliers for goods and services | -8.37%-994.6M | 2.21%-917.8M | -21.10%-938.5M | -13.25%-775M | 28.88%-684.3M | -3.36%-962.2M | -3.33%-930.9M | 11.15%-900.9M | 9.57%-1.01B | 2.48%-1.12B |
| Direct dividend received | 24.71%106M | -6.80%85M | 13.43%91.2M | 38.14%80.4M | -46.01%58.2M | 5.38%107.8M | --102.3M | ---- | 19.82%104M | -78.60%86.8M |
| Direct interest paid | -3.93%-800.5M | -23.27%-770.2M | 1.81%-624.8M | -6.01%-636.3M | -15.38%-600.2M | -3.11%-520.2M | 1.46%-504.5M | 6.98%-512M | ---550.4M | ---- |
| Direct interest received | 2.07%14.8M | 119.70%14.5M | 24.53%6.6M | -15.87%5.3M | 36.96%6.3M | 48.39%4.6M | -3.13%3.1M | -55.56%3.2M | --7.2M | ---- |
| Direct tax refund paid | -3.61%-246.7M | -121.64%-238.1M | 30.74%1.1B | 463.66%841.5M | 11.27%-231.4M | 16.28%-260.8M | -19.62%-311.5M | 16.67%-260.4M | -11.01%-312.5M | 3.79%-281.5M |
| Operating cash flow | 0.05%1.07B | -6.62%1.07B | 29.24%1.15B | 29.59%887.2M | -47.36%684.6M | 0.09%1.3B | 6.06%1.3B | 9.69%1.23B | -36.97%1.12B | -5.98%1.77B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -4.81%-460M | 12.81%-438.9M | -47.19%-503.4M | 4.09%-342M | -143.91%-356.6M | 147.35%812.1M | -322.33%-1.72B | 32.93%-406.1M | -147.46%-605.5M | 310.32%1.28B |
| Net PPE purchase and sale | -7.91%-411.8M | -920.32%-381.6M | -57.14%-37.4M | -11.21%-23.8M | 5.73%-21.4M | 16.24%-22.7M | -31.55%-27.1M | -42.07%-20.6M | 9.38%-14.5M | 18.37%-16M |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---12.5M |
| Net investment purchase and sale | 24.53%-16M | 95.22%-21.2M | -2,657.14%-443.9M | 52.37%-16.1M | -103.14%-33.8M | 166.57%1.08B | -414.16%-1.62B | 44.40%-314.2M | -143.32%-565.1M | 696.21%1.3B |
| Net other investing changes | 10.80%-32.2M | 92.83%-36.1M | -47.19%-503.4M | -13.47%-342M | -25.22%-301.4M | -232.00%-240.7M | -1.68%-72.5M | -175.29%-71.3M | -12,850.00%-25.9M | 99.95%-200K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -4.81%-460M | 12.81%-438.9M | -47.19%-503.4M | 4.09%-342M | -143.91%-356.6M | 147.35%812.1M | -322.33%-1.72B | 32.93%-406.1M | -147.46%-605.5M | 310.32%1.28B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 48.12%-526.2M | -7.74%-1.01B | -1,802.17%-941.3M | 127.39%55.3M | 90.23%-201.9M | -563.47%-2.07B | 155.55%445.7M | -61.79%-802.3M | 83.97%-495.9M | -40.59%-3.09B |
| Net issuance payments of debt | 388.83%315.4M | 36.29%-109.2M | -120.49%-171.4M | 174.79%836.6M | -98.05%-1.12B | -134.17%-564.8M | 367.79%1.65B | -44.67%353.3M | 145.55%638.5M | -156.74%-1.4B |
| Net common stock issuance | ---- | ---- | ---- | ---- | 1,396.01%3.93B | -908.64%-303.6M | ---30.1M | ---- | ---- | ---- |
| Cash dividends paid | 1.41%-848.6M | -11.79%-860.7M | -5.28%-769.92M | -22.76%-731.3M | 50.25%-595.7M | -1.73%-1.2B | -1.84%-1.18B | -1.87%-1.16B | -2.28%-1.13B | -16.43%-1.11B |
| Interest paid (cash flow from financing activities) | ---16M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 14.26%-590.6M |
| Net other financing activities | 151.92%23M | 95.29%-44.3M | -1,802.17%-941.3M | 102.28%55.3M | ---2.42B | ---- | ---- | ---- | ---- | 160.31%7.9M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 48.12%-526.2M | -7.74%-1.01B | -1,802.17%-941.3M | 127.39%55.3M | 90.23%-201.9M | -563.47%-2.07B | 155.55%445.7M | -61.79%-802.3M | 83.97%-495.9M | -40.59%-3.09B |
| Net cash flow | ||||||||||
| Beginning cash position | -56.35%296.4M | -30.62%679M | 158.85%978.7M | 49.45%378.1M | 22.76%253M | 18.45%206.1M | 9.43%174M | 11.42%159M | -24.50%142.7M | -83.61%189M |
| Current changes in cash | 122.23%85M | -28.28%-382.4M | -149.64%-298.1M | 376.21%600.5M | 168.87%126.1M | 56.86%46.9M | 79.04%29.9M | 7.74%16.7M | 133.77%15.5M | 95.02%-45.9M |
| Effect of exchange rate changes | -300.00%-800K | 87.50%-200K | -1,700.00%-1.6M | 110.00%100K | ---1M | ---- | 229.41%2.2M | -312.50%-1.7M | 300.00%800K | 99.04%-400K |
| End cash Position | 28.41%380.6M | -56.35%296.4M | -30.62%679M | 158.85%978.7M | 49.45%378.1M | 22.76%253M | 18.45%206.1M | 9.43%174M | 11.42%159M | -24.50%142.7M |
| Free cash from | 5.66%659.4M | -43.73%624.1M | 28.47%1.11B | 30.19%863.4M | -48.10%663.2M | 0.44%1.28B | 5.62%1.27B | 9.26%1.2B | -36.77%1.1B | -6.52%1.74B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |